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Identity 
Other names: NONO-TFE3 renal cell carcinoma 
Classification 
This renal cell carcinoma, of which there is a single 
reported case, belongs to the family of Xp11 
translocation renal carcinomas. 




Single case report in a 39-year-old male. 
Pathology 
The tumor was described as a papillary renal cell 













The TFE3 gene includes a 5' untranslated region, 8 
exons, and a 3' untranslated region. 
Protein 
TFE3 is a transcription factor with a basic helix-loop-
helix DNA binding domain and a leucine zipper 
dimerization domain. TFE3 contains a nuclear 
localization signal, encoded at the junction of exons 5 
and 6, which is retained within all known TFE3 fusion 
proteins. TFE3 protein is 575 amino acids, and is 
ubiquitously expressed. TFE3, TFEB, TFEC and Mitf 
comprise the members of the microphthalmia 
transcription factor subfamily, which have homologous 
DNA binding domains and in fact bind to a common 
DNA sequence. These four transcription factors may 
homo- or heterodimerize to bind DNA, and they may 




p54nrb/NONO is a 471 amino acid protein with several 
distinctive domains. From N-terminus to C-terminus, it 
has: 
1) an N-terminal basic region composed entirely  
of Proline, Glutamine, and Histidine,  
2) a pair of RNA recognition motifs, 
3) a helix-turn helix domain followed by a series of 
charged amino acids that likely forms a DNA-binding 
unit, 
4) a short C-terminal Proline-rich region. 
PSF and p54nrb/NonO are highly homologous and 
related proteins. p54nrb/NONO has a region of 320 
amino acids with a 71% identity and a 7% similarity to 
a 320 amino acid region within PSF. Both proteins 
have both DNA and RNA binding domains, which  
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underlies their multifunctionality. Indeed, these 
proteins have been implicated in both transcriptional 
activation and splicing. Both proteins are known to 
bind to the DNA binding domains of nuclear hormone 
receptors (such as the thyroid hormone receptor and the 
retinoid X receptor), and modulate transcriptional 
activation. These proteins bind to each other, select the 
same optimal RNA sequence from RNA pools, and 
have been associated with spliceosomes. Both have 
been shown to bind to the C-terminal domain of RNA 
polymerase II, where they may couple pre-mRNA 
splicing and RNA processing. PSF and NonO enhance 
Topoisomerase I cleavage of DNA, and induce its 
jumping to other DNA helices after cleavage. Finally, 
both have been shown to bind and retain defective and 
hyperedited mRNAs within the nucleus, preventing 
translation of mutated proteins. 




5' p54nrb/NONO - 3' TFE3 
Fusion protein 
Description 
The inv (X)(p11.2;q12) results in fusion of virtually the 
entire sequence of NONO/p54nrb with the C-terminal 
portion of the TFE transcription factor that contais the 
basic helix-loop-helix (bHLH) DNA binding domain 
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